“Authorized” Generic Study By FTC To Be Released In 2007
This article was originally published in The Pink Sheet Daily
Executive Summary
FTC is planning to survey approximately 190 firms, but seeks comments on how to reduce the number without undermining the study’s validity.
You may also be interested in...
FTC’s “Authorized” Generics Study Should Have Greater “Qualitative” Focus, GPhA Says
PhRMA, however, contends FTC’s information collection proposal “lacks practical utility” and instead should include more quantitative data.
FTC’s “Authorized” Generics Study Should Have Greater “Qualitative” Focus, GPhA Says
PhRMA, however, contends FTC’s information collection proposal “lacks practical utility” and instead should include more quantitative data.
Unsettling Settlements: FTC Alarmed By Increasing Brand/Generic Deals
The Federal Trade Commission notes the threat of authorized generics, as well as its appeals court loss in the K-Dur case, as reasons for the jump in settlements.